Daniel J. Doyle
Mr. Doyle is the former President of C.R. Bard's Patient Care Division where he grew sales several-fold, substantially raised profit margins, and completed several corporate acquisitions and licensing transactions. He was also Director of Business Development for C.R. Bard Corporate, where he was responsible for growth strategies for Bard Access, Davol, Bard Urology, Bard Medical, and Bard Endoscopic Technologies. At Bard's Patient Care Division, Mr. Doyle headed up a 225-person organization manufacturing and marketing disposable devices and equipment sold to hospitals, physician's offices, and home and long-term care markets.
Mr. Doyle is an expert in strategic planning, market assessments and introductions, and market share expansion. He brings to the table not only professional functionality of the highest order, but also the perspective and wisdom of a successful chief executive of a major healthcare firm. Since he left Bard, he has been called upon to provide these and other services for more than 65 companies, including Johnson & Johnson, GlaxoSmithKline, ConvaTec and many early smaller domestic and foreign companies.